by TractManager | Feb 25, 2021 | News
The Food and Drug Administration (FDA) has granted approval for Amondys 45 (casimersen; Sarepta Therapeutics Inc.) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45...
by TractManager | Feb 24, 2021 | News
The Food and Drug Administration (FDA) has announced a voluntary recall of unused Medtronic Valiant Navion thoracic stent graft systems. The Valiant Navion thoracic stent graft system is indicated for the endovascular repair of all lesions of the descending thoracic...
by TractManager | Feb 22, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of specific lots of the Boston Scientific EMBLEM S-ICD (Subcutaneous Implantable Cardioverter Defibrillator) due to a manufacturing error. The EMBLEM S-ICD is part of the Boston Scientific S-ICD System. The...
by TractManager | Feb 18, 2021 | Emerging Technology Report
TissueGene-C is an injectable solution of normal and genetically modified allogeneic human chondrocytes in development for the treatment of knee osteoarthritis.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Feb 18, 2021 | Health Technology Assessment
Focus of the Report: This report evaluates the use of liquid sublingual immunotherapy (SLIT) for the treatment of allergic rhinitis in the United States.Technology Description: Liquid SLIT involves the daily administration of a diluted dose of an allergen under the...
Recent Comments